USIO:NASDAQUsio, Inc. Analysis
Data as of 2026-08-02 - not real-time
$2.13
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Usio, Inc. (USIO) is trading at $2.13, just above its 20‑day SMA of $2.14 and comfortably above the 50‑day ($1.94) and 200‑day ($1.49) averages, suggesting a short‑term bullish bias. However, the MACD histogram is negative and the signal line is bearish, while RSI sits at a neutral 54, and the 30‑day volatility is an elevated 87%, indicating a choppy price environment.
Fundamentally, the company reports 15.7% revenue growth YoY but remains unprofitable with a –2.4% profit margin and a forward P/E of 106.5 versus an industry average of 32.8, flagging severe overvaluation. The DCF‑derived fair value of $0.21 implies the current price is over 160% above intrinsic estimates. Cash balances ($7.7 M) modestly exceed debt ($4.9 M), and operating cash flow is positive, yet negative earnings and a weak ROE (‑11.6%) undermine confidence. Recent press releases highlight a strategic push into PayFac services, which analysts see as a “crown‑jewel” growth catalyst, but the upside must be weighed against the high valuation and volatility.
Fundamentally, the company reports 15.7% revenue growth YoY but remains unprofitable with a –2.4% profit margin and a forward P/E of 106.5 versus an industry average of 32.8, flagging severe overvaluation. The DCF‑derived fair value of $0.21 implies the current price is over 160% above intrinsic estimates. Cash balances ($7.7 M) modestly exceed debt ($4.9 M), and operating cash flow is positive, yet negative earnings and a weak ROE (‑11.6%) undermine confidence. Recent press releases highlight a strategic push into PayFac services, which analysts see as a “crown‑jewel” growth catalyst, but the upside must be weighed against the high valuation and volatility.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Current price far exceeds DCF fair value
- Negative earnings and high forward P/E
- High 30‑day volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth of ~16% YoY
- Positive operating cash flow
- Increasing trading volume indicating market interest
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Potential upside from PayFac platform rollout
- Improving cash position with low debt
- Sector exposure to fintech disruption
Key Metrics & Analysis
Financial Health
Revenue Growth15.70%
Profit Margin-2.42%
P/E Ratio106.5
ROE-11.61%
ROA-1.03%
Debt/Equity26.86
P/B Ratio3.2
Op. Cash Flow$1.1M
Free Cash Flow$117.5K
Industry P/E32.8
Technical Analysis
TrendBullish
RSI54.0
Support$1.85
Resistance$2.59
MA 20$2.14
MA 50$1.94
MA 200$1.49
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Fair Value$0.21
Target Price$5.58
Upside/Downside162.13%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.05
Volatility87.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.